The “Global mRNA Vaccines and Therapeutics Market: Focus on Application, mRNA Type, Country Data (13 Countries), and Competitive Landscape – Analysis and Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering.
The publisher’s healthcare experts have found that these vaccines and therapeutics market to be one of the most rapidly evolving and dynamic markets, and the global market for these vaccines and therapeutics for COVID-19 vaccines is predicted to grow at a CAGR of -13.50% over the forecast period of 2021-2025.
Moreover, the global market for these vaccines and therapeutics for non-COVID-19 vaccines is predicted to grow at a CAGR of 95.49% over the forecast period of 2026-2031.
The overall global these vaccines and therapeutics market is driven by certain factors, which include growing cases of COVID-19 globally, a favorable regulatory environment, and significant external funding for the development of mRNA-based COVID-19 vaccines.
Key Companies Profiled
Arcturus Therapeutics Holdings Inc., BioNTech SE, CureVac N.V., Daiichi Sankyo Company, Limited., ethris GmbH, GlaxoSmithKline plc, Gennova Biopharmaceuticals Ltd, Moderna, Inc., Pantherna Therapeutics GmbH, Providence Therapeutics, Silence Therapeutics, Translate Bio, VERSAMEB AG, and Verve Therapeutics, Inc.
Key Questions Answered in this Report:
What are the major market drivers, challenges, and opportunities in the global mRNA vaccines and therapeutics market?
What are the key development strategies being implemented by the major players in order to sustain in the competitive market?
What are the key regulatory implications in developed and developing regions for these vaccines and therapeutics market?
How is each segment of the market expected to grow during the forecast period, 2021-2031?
Who are the leading players with significant offerings to the global mRNA vaccines and therapeutics market, and what is the expected market dominance for each of these leading players?
What are the adoption trends for these vaccines and therapeutics in established economies and emerging economies across the world?
Which companies are anticipated to be highly disruptive in the future, and why?
What are the current clinical unmet needs that are being faced in the global mRNA vaccines and therapeutics market?
What are the dynamics of various application areas and countries, which are impacting the global vaccines and therapeutics market?
What are the new market opportunities that are influencing the growth of the global vaccines and therapeutics market?
How is each segment of the market expected to grow during the forecast period from 2021 to 2031? Following are the segment types:
What are the unmet needs currently existing in these vaccines and therapeutics market?